MultiPark: Multidisciplinary research focused on Parkinson´s disease
3911 – 3920 of 3948
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
(
- Contribution to journal › Article
-
Mark
Functional properties of the human ventral mesencephalic neural stem cell line hVM1.
(
- Contribution to journal › Article
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
(
- Contribution to journal › Article
-
Mark
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Rho kinase inhibition protects CA1 cells in organotypic hippocampal slices during in vitro ischemia.
(
- Contribution to journal › Article
-
Mark
Effects of chronic clozapine administration on apolipoprotein D levels and on functional recovery following experimental stroke.
(
- Contribution to journal › Article
-
Mark
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Absolute quantification of cerebral blood flow: correlation between dynamic susceptibility contrast MRI and model-free arterial spin labeling.
(
- Contribution to journal › Article
-
Mark
The Accuracy of Short Clinical Rating Scales in Neuropathologically Diagnosed Dementia.
(
- Contribution to journal › Article